The Effect of Coronary Artery Disease and Related Drugs on Sexual Activity in Turkish Society

dc.contributor.authorDuzel, Baris
dc.contributor.authorAkgün, Didar Elif
dc.contributor.authorŞafak, Özgen
dc.contributor.authorNaser, Abdulrahman
dc.contributor.authorYildirim, Tarik
dc.contributor.authorArslan, Abdulla
dc.contributor.authorAciksari, Gonul
dc.date.accessioned2025-07-03T21:09:41Z
dc.date.issued2023
dc.departmentBalıkesir Üniversitesi
dc.description.abstractObjective: Sexual dysfunction after acute coronary syndrome (ACS), is a frequently encountered problem in clinical practice. The aim of our study is to determine the time it takes for patients to switch to a healthy sexual life, which is one of the basic elements of a healthy social life, after a cardiovascular event in Turkish society and investigation of the effect of drugs related to ACS on sexual activity. Method: In our study, volunteer women and men who had a cardiovascular event at least 3 months before and were sexually active before the ACS between January 2017-December 2019 were evaluated using a closed questionnaire. The demographic characteristics of the patients, their comorbidities and medications, and their sexual activity levels before and after the ACS were compared. Results: After ACS, sexual dysfunction developed in 36% (n=117) of the patients. In the group with sexual dysfunction, heart failure [21% (n=25) - 9% (n=18) - p=0.001], chronic renal failure [9% (n=11) - 0% (n=0) p<0.001], and BPH presence [34% (n=40)- (11% (n=23) p<0.001] were higher. Similarly, beta-blocker use [95% (n=111) - 84% (n=172) p=0.001] and ACE-I/ARB use [62% (n=73) - 54% (n=111) p=0.05] were also higher in participants with sexual dysfunction. Conclusion: In our study, an increase in the prevalence of sexual dysfunction was observed in patients with multiple comorbidities, especially heart failure. Sexual dysfunction was found to be higher in patients using beta-blockers.
dc.identifier.doi10.4274/BMB.galenos.2022.2022-10-089
dc.identifier.endpage20
dc.identifier.issn2547-9431
dc.identifier.issue1
dc.identifier.startpage13
dc.identifier.trdizinid1254996
dc.identifier.urihttps://doi.org/10.4274/BMB.galenos.2022.2022-10-089
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1254996
dc.identifier.urihttps://hdl.handle.net/20.500.12462/19614
dc.identifier.volume8
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofBağcılar Tıp Bülteni
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_TR_20250703
dc.subjectSexual dysfunction
dc.subjectbeta-blocker
dc.subjectAcute coronary syndrome
dc.subjectTurkish society
dc.titleThe Effect of Coronary Artery Disease and Related Drugs on Sexual Activity in Turkish Society
dc.typeArticle

Dosyalar